Integrating GlycanAge with DUTCH, Full Body MRI and Other Premium Diagnostics

Combining GlycanAge with premium diagnostics like DUTCH hormone testing, full body MRI, or comprehensive blood panels gives you the fullest possible picture of health: structural findings, hormone metabolites, standard blood chemistry, and the chronic inflammation driving biological aging, all in one integrated view. None of these tools replace each other. Each measures a different layer of biology, and GlycanAge fills the layer the others cannot see: active immune aging and inflammaging, the low-grade, chronic inflammation that builds with age and drives disease risk. For anyone already investing in premium diagnostics, glycan testing is the piece that shows whether everything else you are doing is actually changing your underlying biology.

This article answers the questions people typically ask once they already own, or are considering, a stack of longevity diagnostics and want to know how GlycanAge fits alongside them.

Building a diagnostics stack for patients or clients? Read GlycanAge for Healthcare Providers, Functional Medicine Clinics & Corporate Wellness Programs.

What is the difference between GlycanAge and a full body MRI or DUTCH test?

A full body MRI screens for structural abnormalities, and a DUTCH test measures hormone metabolites in urine, while GlycanAge measures the active inflammatory biology behind biological aging. These are fundamentally different categories of information: structural imaging finds what has already changed physically, hormone panels quantify a specific metabolic pathway at one point in time, and glycan testing tracks a systemic signal that shifts with lifestyle, hormones, stress, and medical interventions. GlycanAge analyses glycans, complex sugars attached to immunoglobulin G (IgG) antibodies, and the ratio between pro-inflammatory and anti-inflammatory glycan structures reveals how fast your immune system is aging. None of these tools compete with each other. A patient might use MRI to rule out structural disease, DUTCH to understand hormone metabolism, and GlycanAge to track whether the interventions built around those findings are working at a biological level. 

Should I run GlycanAge alongside standard blood work, or instead of it?

Run GlycanAge alongside standard blood work, not instead of it: the two are complementary, not competing. If you already run annual blood work, GlycanAge adds the missing inflammatory and immune-aging layer, the piece that tells you whether your results are translating into slower biological aging. Standard blood markers are designed to detect acute or advanced dysfunction, while glycans reflect long-term immune balance and aging risk, which means an imbalanced glycan profile can appear years before blood work shows anything unusual. In clinical use, the recommended approach is to use targeted blood testing to rule out simple disruptions such as vitamin deficiencies, thyroid issues, or metabolic dysfunction, then use GlycanAge to track the systemic, longer-term trend those panels cannot capture. If your blood panel comes back normal but you suspect something is still driving fatigue, poor recovery, or slow progress, a pro-inflammatory glycan profile can reveal shifting immune balance despite "normal" labs.

Which additional blood markers actually complement a GlycanAge result?

The most useful additions are a minimal set of markers that rule out basic deficiencies and assess the psychoneuroimmunological (PNI) system, the network linking your nervous, endocrine, and immune systems, rather than a large generic panel. Clinical guidance recommends three steps: first, eliminate obvious deficiencies or imbalances that are easy to correct; second, assess key PNI system markers influencing immune aging; third, track status over time to support long-term intervention strategy. Glycans on IgG antibodies are highly sensitive to changes across this PNI system, which is why they function as an unusually integrative biomarker of systemic balance rather than a single-pathway readout. Rather than expecting a direct, marker-by-marker correlation between GlycanAge and blood work, the more useful clinical frame is pattern recognition across both data sets over time.

Does a gut microbiome or stool test add anything GlycanAge doesn't already capture?

Yes: microbiome sequencing can reveal dysbiosis, leaky gut, or localized inflammation that may be contributing to immune aging in ways a glycan result alone will not specify. The gut microbiome significantly influences immune regulation and glycan composition, so stool testing is a reasonable additional layer for anyone whose GlycanAge result shows a pro-inflammatory pattern without an obvious lifestyle or hormonal explanation. Think of it as a diagnostic follow-up question rather than a replacement: GlycanAge tells you that immune aging is accelerated, and microbiome testing can help identify one possible mechanism behind it.

How is GlycanAge different from an epigenetic clock if I'm already tracking DNA methylation?

Epigenetic clocks estimate age from DNA methylation patterns, which change slowly and reflect cumulative, longer-term biology, making short-interval retesting impractical for validating a specific protocol. GlycanAge measures current, active inflammatory biology rather than a historical methylation signature, which is why it can be retested on a clinically useful timeline, typically 3 to 4 months for pharmaceutical or hormone-based interventions and 6 to 12 months for lifestyle-based ones. As Dr. Joseph Raffaele, MD, Founder of Raffaele Medical in New York City, put it: "There's no single biomarker that can function for everything, but glycans are predictive, they're responsive, they're stable. They are such a great indicator of inflammation and a very, very good biomarker of aging". If you are already running an epigenetic clock, GlycanAge is not a redundant second opinion; it is measuring a different, faster-moving biological signal.

Can a DNA test tell me whether my current health interventions are working?

No, DNA tests reveal fixed genetic potential, predispositions that do not change, which makes them useful for risk stratification but unable to show whether this quarter's protocol is working. A genetic test is a starting point, not a tracking tool. GlycanAge picks up where DNA testing stops, measuring the modifiable, lifestyle-responsive biology that sits downstream of your genetics, which is the layer that actually shifts when you change your diet, start hormone therapy, or reduce chronic stress. 

"The good thing about GlycanAge is that it's responsive to interventions. It can tell me whether what I'm doing is actually good for me or not."

— Prof. Gordan Lauc, Co-Founder and Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb 

If you have already completed a DNA panel, adding GlycanAge gives that genetic data direction: not just what you are predisposed to, but what your biology is actually doing right now.

How often should I retest GlycanAge if I'm also tracking DUTCH, MRI, or other diagnostics on a different schedule?

Retest GlycanAge on its own biology-driven schedule rather than syncing it to the retest cadence of imaging or hormone panels, since each tool changes on a different timeline. For pharmaceutical and hormone replacement therapy protocols, including hormone titration and peptide regimens, glycan shifts are typically measurable within 3 to 4 months, allowing early assessment and adjustment. For lifestyle-based protocols such as nutrition, exercise, sleep, and stress management, glycan shifts occur more gradually, and 6 to 12 months is the window that captures a genuine, sustained trend rather than noise. Full body MRI is typically run annually or every few years for structural surveillance, and DUTCH testing is often repeated around specific hormone titration decisions, so the three diagnostics naturally sit on different clocks rather than one shared schedule. Retesting GlycanAge too early on a lifestyle-only programme will not reflect real biological remodeling, so hold the line at the appropriate window even if your other diagnostics are due sooner.

What should I actually ask my clinician when bringing GlycanAge into an existing diagnostic workup?

Ask your clinician to treat GlycanAge as the layer that validates whether findings from your other diagnostics are translating into slower biological aging, not as a replacement for any of them. A useful clinical question is: "Given my DUTCH and blood work results, what protocol are we starting, and when should we retest GlycanAge to check whether it's working?" Baselining before an intervention, whether hormone replacement therapy, a peptide regimen, or a structured lifestyle change, establishes your starting biological age and glycan index pattern, giving both of you a fixed point to retest against.

"I would love to monitor my patients before they start HRT, because we want to know how quickly we can reverse this pro-inflammatory change. This inflammation is really crucial to our future health."

— Dr Louise Newson, GP and Menopause Specialist, Founder of Newson Health 

 From there, the practitioner conversation shifts from a single number to a trend: is your biological age moving in the right direction relative to your baseline, and at what rate.

What does a GlycanAge result actually include, and how does it fit into a broader dashboard of diagnostics?

A GlycanAge report includes your biological age result, five glycan indexes, glycan insights, disease-association patterns, influencing factors, and personalised action steps, delivered alongside a 1:1 Result Interpretation Call with a longevity specialist. Ninety-six percent of GlycanAge users report being extremely satisfied with their interpretation call, which is designed to translate the result into a concrete plan rather than leave you with a number to interpret alone. In a broader diagnostic stack, this makes GlycanAge the integration point: MRI shows you structure, DUTCH shows you hormone metabolites, standard blood panels show you acute chemistry, and GlycanAge shows you whether all of it is adding up to slower biological aging over time. 

"It would be nice to see glycans, proteins, and methylation in a large cohort on the same individuals, so we can really look at whether there are additive contributions. My guess is there will be."

— Prof. Riccardo Marioni, Chair of Molecular Epidemiology of Ageing, University of Edinburgh 

Biological age testing works best as one coordinated system rather than a stack of disconnected reports. If you are already investing in premium diagnostics and want the layer that tells you whether your interventions are actually changing your biology, learn more on our biological age testing page, or order a test kit and book your 1:1 result interpretation call to see where you stand today.

For clinicians building GlycanAge into an existing diagnostic workflow alongside DUTCH, imaging, or blood panels, see how it supports intervention monitoring on our Healthcare Providers page. 

Explore for clinicians →

External sources

• https://pmc.ncbi.nlm.nih.gov/articles/PMC4049143/ — Krištić J, Vučković F, Menni C, Klarić L, Keser T, Beceheli I, et al. Glycans are a novel biomarker of chronological and biological ages. J Gerontol A Biol Sci Med Sci. 2014;69(7):779–789.